{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:12:32Z","timestamp":1769116352050,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,3,22]],"date-time":"2007-03-22T00:00:00Z","timestamp":1174521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2007,8,13]]},"DOI":"10.1007\/s00430-007-0043-4","type":"journal-article","created":{"date-parts":[[2007,3,21]],"date-time":"2007-03-21T11:53:20Z","timestamp":1174478000000},"page":"227-231","source":"Crossref","is-referenced-by-count":36,"title":["Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice"],"prefix":"10.1007","volume":"196","author":[{"family":"Alka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaushik","family":"Bharati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. P. S.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhanshu","family":"Vrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,3,22]]},"reference":[{"key":"43_CR1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14787210.4.2.313","volume":"4","author":"K Bharati","year":"2006","unstructured":"Bharati K, Vrati S (2006) Japanese encephalitis: development of new candidate vaccines. Expert Rev Anti Infect Ther 4:313\u2013324","journal-title":"Expert Rev Anti Infect Ther"},{"key":"43_CR2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0042-6822(91)90471-M","volume":"181","author":"D Cecilia","year":"1991","unstructured":"Cecilia D, Gould EA (1991) Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology 181:70\u201377","journal-title":"Virology"},{"key":"43_CR3","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","volume":"75","author":"WD Crill","year":"2001","unstructured":"Crill WD, Roehrig JT (2001) Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 75:7769\u20137773","journal-title":"J Virol"},{"key":"43_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0065-3527(03)61003-1","volume":"61","author":"SB Halstead","year":"2003","unstructured":"Halstead SB, Jacobson J (2003) Japanese encephalitis. Adv Virus Res 61:103\u2013138","journal-title":"Adv Virus Res"},{"key":"43_CR5","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1110\/ps.8.8.1668","volume":"8","author":"RB Kapust","year":"1999","unstructured":"Kapust RB, Waugh DS (1999) Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 8:1668\u20131674","journal-title":"Protein Sci"},{"key":"43_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/338015","volume":"185","author":"R Kaur","year":"2002","unstructured":"Kaur R, Sachdeva G, Vrati S (2002) Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. J Infect Dis 185:1\u201312","journal-title":"J Infect Dis"},{"key":"43_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/viro.1999.9859","volume":"261","author":"AS Kolaskar","year":"1999","unstructured":"Kolaskar AS, Kulkarni-Kale U (1999) Prediction of three-dimensional structure and mapping of conformational epitopes of envelope glycoprotein of Japanese encephalitis virus. Virology 261:31\u201342","journal-title":"Virology"},{"key":"43_CR8","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/JVI.77.4.2600-2606.2003","volume":"77","author":"CW Lin","year":"2003","unstructured":"Lin CW, Wu SC (2003) A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. J Virol 77:2600\u20132606","journal-title":"J Virol"},{"key":"43_CR9","first-page":"991","volume-title":"Fields virology","author":"BD Lindenbach","year":"2001","unstructured":"Lindenbach BD, Rice CM (2001) Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 991\u20131041","edition":"4th edn"},{"issue":"Pt 8","key":"43_CR10","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1099\/0022-1317-70-8-2037","volume":"70","author":"PW Mason","year":"1989","unstructured":"Mason PW, Dalrymple JM, Gentry MK, McCown JM, Hoke CH, Burke DS, Fournier MJ, Mason TL (1989) Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol 70(Pt 8):2037\u20132049","journal-title":"J Gen Virol"},{"key":"43_CR11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0889-8561(03)00102-4","volume":"23","author":"AM Plesner","year":"2003","unstructured":"Plesner AM (2003) Allergic reactions to Japanese encephalitis vaccine. Immunol Allergy Clin North Am 23:665\u2013697","journal-title":"Immunol Allergy Clin North Am"},{"key":"43_CR12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/161.5.878","volume":"161","author":"JD Poland","year":"1990","unstructured":"Poland JD, Cropp CB, Craven RB, Monath TP (1990) Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J Infect Dis 161:878\u2013882","journal-title":"J Infect Dis"},{"key":"43_CR13","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H (1938) A simple method of estimating 50 per cent end-points. Am J Hyg 27:493\u2013497","journal-title":"Am J Hyg"},{"key":"43_CR14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","volume":"375","author":"FA Rey","year":"1995","unstructured":"Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375:291\u2013298","journal-title":"Nature"},{"key":"43_CR15","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/JVI.77.6.3487-3494.2003","volume":"77","author":"M Saini","year":"2003","unstructured":"Saini M, Vrati S (2003) A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge. J Virol 77:3487\u20133494","journal-title":"J Virol"},{"key":"43_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0168-1702(96)01323-8","volume":"43","author":"SA Seif","year":"1996","unstructured":"Seif SA, Morita K, Igarashi A (1996) A 27 amino acid coding region of JE virus E protein expressed in E. coli as fusion protein with glutathione-S-transferase elicit neutralizing antibody in mice. Virus Res 43:91\u201396","journal-title":"Virus Res"},{"key":"43_CR17","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/0264-410X(95)00097-K","volume":"13","author":"SA Seif","year":"1995","unstructured":"Seif SA, Morita K, Matsuo S, Hasebe F, Igarashi A (1995) Finer mapping of neutralizing epitope(s) on the C-terminal of Japanese encephalitis virus E-protein expressed in recombinant Escherichia coli system. Vaccine 13:1515\u20131521","journal-title":"Vaccine"},{"key":"43_CR18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4269\/ajtmh.1998.58.655","volume":"58","author":"M Simmons","year":"1998","unstructured":"Simmons M, Nelson WM, Wu SJ, Hayes CG (1998) Evaluation of the protective efficacy of a recombinant dengue envelope B domain fusion protein against dengue 2 virus infection in mice. Am J Trop Med Hyg 58:655\u2013662","journal-title":"Am J Trop Med Hyg"},{"key":"43_CR19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1263\/jbb.99.303","volume":"99","author":"SM Singh","year":"2005","unstructured":"Singh SM, Panda AK (2005) Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 99:303\u2013310","journal-title":"J Biosci Bioeng"},{"key":"43_CR20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0042-6822(87)90144-9","volume":"161","author":"H Sumiyoshi","year":"1987","unstructured":"Sumiyoshi H, Mori C, Fuke I, Morita K, Kuhara S, Kondou J, Kikuchi Y, Nagamatu H, Igarashi A (1987) Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 161:497\u2013510","journal-title":"Virology"},{"key":"43_CR21","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1099\/0022-1317-80-7-1665","volume":"80","author":"S Vrati","year":"1999","unstructured":"Vrati S, Agarwal V, Malik P, Wani SA, Saini M (1999) Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth. J Gen Virol 80:1665\u20131671","journal-title":"J Gen Virol"},{"key":"43_CR22","unstructured":"World Health Organization (1998) Japanese encephalitis vaccines. Wkly Epidemiol Rec 73:337\u2013344"},{"key":"43_CR23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-1702(97)00098-1","volume":"51","author":"SC Wu","year":"1997","unstructured":"Wu SC, Lian WC, Hsu LC, Liau MY (1997) Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence. Virus Res 51:173\u2013181","journal-title":"Virus Res"},{"key":"43_CR24","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0264-410X(03)00042-2","volume":"21","author":"SC Wu","year":"2003","unstructured":"Wu SC, Yu CH, Lin CW, Chu IM (2003) The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity. Vaccine 21:2516\u20132522","journal-title":"Vaccine"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-007-0043-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-007-0043-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-007-0043-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:11:39Z","timestamp":1559067099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-007-0043-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,22]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8,13]]}},"alternative-id":["43"],"URL":"https:\/\/doi.org\/10.1007\/s00430-007-0043-4","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,22]]}}}